|Most of the foreign countries including USA, Australia, European countries etc. have not recognized Ayurveda, Siddha and Unani, as systems of medicine, therefore practice of these systems and marketing of their products as medicines faces problems. The medicines of these systems are generally manufactured in India as per the standards and Good Manufacturing Practices in accordance with the Drugs and Cosmetics Act, 1940 and Rules thereunder but are often exported by the industry to such countries as food supplements or dietary supplements because of non-fulfillment of the regulatory requirements of the importing countries.
The Government has set up Pharmacopoeia Commission of Indian Medicine and Homoeopathy and Pharmacopoeia Committees to develop the standards of Ayurvedic, Siddha and Unani drugs. Quality standards of Ayurvedic, Siddha and Unani (ASU) drugs including the permissible limits of heavy metals, pesticide residue, aflatoxins and microbial load are being published in the respective Pharmacopoeias and Good Manufacturing Practices (GMP) have been notified under the provisions of Drugs and Cosmetics Rules, 1945. System of WHO-GMP Certification and quality certification of ASU medicines by Quality Council of India on voluntary basis is in place for the industry interested to export these medicines. A Central Scheme has been implemented through which ASU drug industry can avail financial support for registration of products in foreign countries, preparation of drug dossiers and participation in international fairs and exhibitions.
This information was given by the Minister of State, AYUSH(IC), Shri Shripad Yesso Naik in a written reply to a question in Rajya Sabha today.